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It is one of the main charms of blood
coagulation that advanced biochemistry is
continuous to everyday medical practice and
vice versa. Common clinical facts hide the
most enchanting enzymology. The pro-
thrombin time (PT, thromboplastin time,
Quick time) and the activated partial throm-
boplastin time (APTT) are perfect examples.
Both are commonly used in the clinical labo-
ratory as global tests for the function of the
coagulation system and for the control of
anticoagulant therapy. They are at the basis
of the classical one-stage clotting factor de-
terminations. Practice has taught us that the
PT is perfectly suited for the control of anti-
coagulant therapy but not for measuring the
effect of heparin, whereas the APTT can
serve both purposes. Only recently was it
found out why: the length of the APTT is
primarily determinated by the time neces-
sary for the activation of factor VIII by
thrombin [1]. Now thrombin, of course, is
the final enzyme of the coagulation cascade,
whereas factor VIII is one of the factors nec-
essary for its formation. The product acti-
yates one of the proteins instrumental in its
own formation: a clearcut case of feedback
activation. Obviously, if thrombin is quickly
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inactivated, as in the presence of heparin,
the activation of factor VIII will take longer
and the APTT will be prolonged. But one
answer immediately engenders a number of
questions: How does the frrst molecule of
thrombin arise without the help of any acti-
vated factor VIII?, is there another way to
activate factor VIII?, is factor VIIIa not ab-
solutely necessary for thrombin formation in
the APTT? And again: If the feedback effect
shows up so readily with factor VIII in the
intrinsic system, why don't we see it in the
supposedly completely analogous situation
with factor V, either intrinsically or extrinsi-
cally?
Thus, from a simple observation in the
clinical laboratory one lands in a tangle of
biochemical questions of the most interest-
ing kind.
In the present issue, several articles are
devoted to the discussion of feedback mech-
anisms in coagulation. The manuscripts
were based upon the presentations of the
authors at a symposium during the 21st
Meeting of the Federation of the European
Biochemical Societies organised by Prof.
Elddi Susan and the present author (HCH).
The reader will see how they span a wide
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range of interest, from fundamental to clini-
cal. As a prelude to the more specialized arti-
cles that follow, we start with a short intro-
duction to the feedback reactions ofcoagula-
tion as we understand them now.
The Mechanism of Thrombin Formation
It is impossible to discuss feedback reac-
tions in coagulation without first giving a
general outline of the biochemical mecha-
nism that leads to thrombin formation.
Proenzyme to enzyme conversions form the
backbone of this mechanism. As early as
I 894, Pekelh anng l2l published experiments
in which he isolated a prothrombin-contain-
ing fraction free offibrinogen and fibrinogen
free of prothrombin. He observed that a tis-
sue extract would form thrombin in his pro-
thrombin preparation and drew the correct
conclusion that he had isolated the proen-
zyme of the clotting enzyme. Incidentally,
this is to our knowledge even the first time
that a proenzyme was isolated and explicitly
recognized. Clotting was recognized in 1963
to consist of a series of proenzyme to enzyme
conversions 13, 41. At that time it was
thought that all clotting factors were proen-
zymes which were converted into enzymes in
a strict sequential order: the clotting cascade.
Now we know that only the vitamin-K-
dependent clotting factors II (prothrombin),
VII, IX and X are the proenzymes. The
sequence of activation is either VII + X + II
or, alternatively VII -> IX -+ X -+ II (ftg. 1).
Each of these activations takes place at a
phospholipid surface in the presence of an
accelerating helper protein, which is also ad-
sorbed onto that surface (fi9.2). These
helper proteins may conveniently be called
paraenzymes. We prefer this term to the
more commonly used'protein cofactor' be-
cause in general enzymology is by defrnition
a second substrate (e.g. NADH), and thus
suggests a mechanism that is quite different
from what actually happens. The complete
enzyme complex thus consists of the actual
enzyme, that carries the active site (VII, IX
or X), the paraenzyme [tissue factor (-throm-
boplastin), VIIIa or Val and the procoagu-
lant phospholipid on which both are ad-
sorbed. In order to be an effrcient procoagu-
lant surface, the phospholipid has to be neg-
atively charged. For all practical purposes, it
has to contain phosphatidylserine.
In terms of enzyme kinetics, the phospho-
lipid decreases the K- of the reaction and
the paraenzyme increases the k""t. This
means that, in the presence of a procoagu-
lant phospholipid surface, the enzyme is eas-
ily saturated at normal plasma concentra-
tions of the substrate, whereas it is far from
saturated in free solution. The effect on h"t
means that the presence of the paraenzyme
increases the number of substrate molecules
that one molecule of enzyme per unit time
about one thousandfold. In terms of physiol-
ogy, the phospholipid localizes the reaction
at the site of a lesion in the vessel (any
wound, but also e.g. an atheromatous lesion)
and the paraenzyme serves to regulate the
velocity of the reaction. The positive and
negative feedback reactions of coagulation
play their role primarily via activation and
inactivation of the paraenzymes.
Positive and Negative Feedback in the
Activation of Factor X
Coagulation starts because factor VII
combines with tissue factor, an integral
membrane protein that occurs in cells sur-
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Fig. 1. The proenzyme to enzyme conversions in thrombin generation.
Fig.2. The paraenzymes and phospholipids in thrombin generation.
Fig.3. The negative feedback in factor X activation.
Tabte ll The phospholipid-bound complexes ofthe clotting system
Enzyme Paraenzyme Substrate Activator Inactivator
VII(a)
IXa
Xa
IIa
APC
TPL
VIIIa
Va
Thr.mod
(prot.S?)
X,IX
X
II
Prot.C
Va,VIIIa
Xa
IIa
IIa
EPI-Xa
APC
APC
rounding the blood vessels and in the skin.
In contrast to the other activation steps, here
the phospholipid and the paraenzyme are
always tightly bound together. Even though
factor VII is not activated it shows already a
certain, low activity when complexed to
thromboplastin [see ref. 5 for further discus-
sion and referencesl. It therefore can activate
some factor X. Factor Xa, in a first positive
feedback reaction then activates factor VII,
which now becomes 10-100 times as active
and starts to activate factor Xa at a high
velocity. Factor Xa in plasma finds the ex-
trinsic pathway inhibitor (EPI) [6, 7]. The
factor Xa-EPI complex is a very effrcient
inhibitor of the factor Vlla-thromboplastin
complex. This is the negative feedback in
factor X activation (frg. 3). The presence of
factor Xa produces an inhibitor of the factor
X-activating enzyme. The result is a sudden
wave of factor Xa generation. A comparable
mechanism acts on factor IX. After the acti-
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Activation of Platelets
All cell membranes that have been in-
vestigated show an asymmetry of their
phospholipid bilayer. What imports here is
that the procoagulant phosphatidylserine is
always found at the inside. This makes that
intact cells will not provoke thrombin for-
mation and hence do not cause thrombosis.
There is one exception: the activated plate-
let. A transbilayer lipid movement makes
that platelets, when they are activated,
have at the outside the phosphatidylserine
that originally is found at the inside only.
The intact activated platelet thus becomes
procoagulant [9]. Two physiological platelet
activators produce this phenomenon: colla-
gen and thrombin. In combination, they
are even more active than the sum of their
individual actions. The relative importance
of the activators is dependent upon the
platelet concentration. At 106 platelets/ml,
collagen is more potent than thrombin, but
at the normal concentration (108 plate-
lets/ml plasma), thrombin is perfectly effec-
tive at a concentration as low as lO nM
(0.050/o f the plasma prothrombin concen-
tration), and collagen has no additional ef-
fect [10].
It is easy to imagine a physiological sce-
nario that shows the importance of these
observations. As soon as a wound occurs the
platelets gain access to the perivascular con-
nective tissue, adhere to the connective tis-
sue matrix (collagen, etc.) and produce phos-
phatidylserine at their outside surface. This
phosphatidylserine fosters thrombin forma-
tion and by this thrombin more platelets will
become activated, aggregating to those al-
ready adhering to the collagen. In the inter-
stices of the platelet aggregate, plasma is
caught. Activated clotting factors will not be
washed away by the blood flowing by. The
Fig.4. The positive feedback effects of throm-
bin.
vation wave is over, the only way to form
more factor Xa is via the factor IXa-factor
Vllla-phospholipid complex. This may ex-
plain why hemophiliacs usually bleed in
thromboplastin-poor organs like muscles
and joints, rather than in thromboplastin
rich organs like brain and lung. The quanti-
tative kinetics of factor Xa activation in
plasma still have to be determined. Prelimi-
nary results suggest hat the pulse duration is
always l-2 min and that the height of the
pulse is determined by the amount of throm-
boplastin, but not linearly [8].
The Thrombin-Dependent Positive
Feedbacks
Thrombin has three positive feedback ef-
fects on its own formation: (a) The activa-
tion of platelets, (b) the activation of factor
VIII and (c) the activation of factor V
(fre.4).
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concentration of factor V in the crevices of
the platelet plug will also be high, because it
is released by the platelets. This will increase
the local concentration of factor V, that in
plasma is significantly lower than that of fac-
tor Xa (25 and 200 nM. The conditions are
therefore perfectly suited to optimize throm-
bin generation: plenty ofprocoagulant phos-
pholipid and of clotting factors.
The question of the origin of the first
traces of activated clotting factor (Xa or
thrombin) remains unsolved, however. We
will discuss it in more detail below.
Activation of Factors V and VIII
Factors V and VIII in the form in which
they circulate in the plasma are incapable of
serving as a paraenzyme in the clotting
mechanism. They have to undergo limited
proteolysis first. Thrombin is a very efficient
enzyme here. Again the question remains
where the frrst traces of factor V (VIII) acti-
vator come from. It is sure that factor Xa can
serve this function lll, l2l, but it has also
been shown that in plasma it hardly does
[13]. When thrombin inactivation is en-
hanced, e.g. by the presence of heparin, the
activation of factor VIII is retarded, which
shows up as a prolongation of the APTT [for
a discussion ofthe effects ofheparin also see
ref. 141. The question of why the retardation
ofthe activation offactor V does not show in
a prolongation of the PT remains unsolved.
In fact, the precise course of events during
the prephase of thrombin formation (the lag
phase) remains an enigma and requires thor-
ough further investigation. One of the rea-
sons for the observed difference between fac-
tors V and VIII possibly may be the fact that
factor VIII circulates in a tight complex with
Von Willebrand factor (VWF). The factor
VIII activator, whatever it may be, therefore
has to present itself in the fluid phase of the
plasma in order to proteolyse the factor VIII
that is attached to the VWF. After this pro-
teolysis, factor VIIIa shows an affinity for
procoagulant phospholipid rather than for
VWF. Factor V, that has no plasma carrier,
may possibly present itself at the phospho-
lipid surface even before its activation and
phospholipid bound activators like factor Xa
or meizothrombin may attack it. Anyhow,
thrombin (resp. factor Xa) formation ap-
pears to be critically dependent upon the
presence of factor Va (resp. factor VIIIa) and
the activation of factor V (resp. factor VIII)
is critically dependent upon the presence of
thrombin. The physiological mechanism
that breaks this stalemate position remains
to be found.
Thrombin-Dependent Negative Feedbacks
On normal endothelium one frnds the
membrane (glyco)protein thrombomodulin,
which has a high affrnity for thrombin.
Thrombin adsorbed to thrombomodulin
converts protein C into activated protein C
(APC). APC attacks phospholipid-bound fac-
tor Va and factor VIIIa and destroys its
activity by proteolytic action. The cofactor
thus can no longer serve its helper function
[5] (frg.5). By this mechanism, thrombin
inhibits its own formation. Again, as with
factor Xa, the active enzyme first enhances
and later inhibits its own formation. Com-
pared to the situation with factor Xa, how-
ever, the number of reactions in the inhibi-
tory pathway is longer. Also here the pres-
ence of intact endothelium downstream of
the thrombin source is necessary. This may
lead to the speculation that this mechanism
is primarily suitable for the prevention of the
t94 Hemker/Kessels
Pr.C
Fig.S. The negative feedback of thrombin via
activated protein C.
extension of the thrombotic process to unaf-
fected parts ofthe vascular bed, downstream
of the lesion.
Continuous Extravascular Coagulation?
The proenzymes of blood coagulation are
comparatively small molecules (< 70,000).
The paraenzymes are of a much higher mo-
lecular weight (> 300,000). This makes that
under normal circumstances the proenzymes
may appear in the extravascular fluid
whereas the paraenzymes will not. The phos-
pholipids are present in the blood platelets
which will not normally leave the vascular
bed either. This opens the interesting possi-
bility that at the sites where thromboplastin
is present, i.e. in a layer ofperivascular cells,
factor VII is activated and that this factor, at
a yery low pace, may activate some factor X.
This mechanism may produce low concen-
trations of thrombin near the cells that carry
thromboplastin at their surface. As soon as
there is a breach in a blood vessel the paraen-
zymes will appear, will be activated by the
thrombin present, and speed up the process
tremendously. Also the platelets arrive, ad-
here to the intentitial material of the con-
nective tissue, flip-flop readily because of the
thrombin already present and form a locus
of high thrombogenic activity.
Anyhow, this is necessarily only part of
the story, because blood drawn under cir-
cumstances that practically exclude contact
with tissue still develops thrombin.
Nonlinearity and Flow Phenomena
Enzyme systems in which the quasi sta-
tionary rate ofa key reaction depends upon
an enzyme or substrate concentration in an
S-shaped, hysteresis type of function, are
called nonlinear (frg.6). This type of re-
sponse accounts for a number of properties
that are commonly found in biological sys-
tems, such as thresholds, i.e. sudden changes
of output at a given level of input; memory
i.e. behavior dependent upon the previous
history; morphogeneszs i.e. the formation of
spatial structures. These phenomena are ob-
served only at a certain degree of complexity
of the enzyme system. Sel'kov [16] investi-
gated the minimal requirements of com-
plexity for nonlinearity to occur. One of his
models is depicted in figure 7. It is imme-
diately evident that this general mechanism
applies to thrombin formation. It may there-
fore be expected that, e.g., threshold phe-
nomena are observed. This may be the
background to the common observation
that thrombosis occurs explosively when a
thrombogenic threshold is passed and that it
can be prevented by increasing this thresh-
old via inhibition of the thrombin-generat-
ing mechanism, i.e. by oral anticoagulation
or by heparin administration. In simulation
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Fig.6. Nonlinear relation between substrate con-
centration and reaction velocity (from ref. 16l.
Fig.7. One of the nonlinear mechanisms of
Sel'kov. [from ref. 16].
experiments it is indeed observed that below
a critical limit of factor Xa thrombin genera-
tion will not ensue, whereas above that limit
it is explosive [6].
It appears that no realistic picture of the
reaction mechanism of thrombin formation
can be sketched without taking positive and
negative feedback reactions into account.
This may be a necessary level of compli-
cation, it is by no means sufficient. As al-
ready hinted at above, it is impossible to
obtain a picture of thrombin generation that
approaches reality without taking into ac-
count that in (patho)-physiology the genera-
tion of thrombin is not a merely chemical
process but linked to the appearance of mac-
roscopic procoagulant surfaces. Recent re-
search made it clear that such surfaces offer
conditions that differ essentially from those
in a test tube where the phospholipids are
present as a suspension ofvesicles [17]. This
indicates that, in order to obtain a realistic
picture of thrombin generation under physi-
ological and pathological conditions, one has
to study it in the presence of macroscopic
surfaces and under flow conditions. The ele-
gant experiments started
[ 8] may be at the basis
ment here.
by Gemmel et al.
of a new develop-
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